
Mirum Pharmaceuticals Inc
NASDAQ:MIRM

Intrinsic Value
The intrinsic value of one
MIRM
stock under the Base Case scenario is
44.92
USD.
Compared to the current market price of 50.73 USD,
Mirum Pharmaceuticals Inc
is
Overvalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Mirum Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Mirum Pharmaceuticals Inc
Balance Sheet Decomposition
Mirum Pharmaceuticals Inc
Current Assets | 410.8m |
Cash & Short-Term Investments | 277.7m |
Receivables | 95.9m |
Other Current Assets | 37.3m |
Non-Current Assets | 279.4m |
Long-Term Investments | 20.9m |
PP&E | 8.8m |
Intangibles | 243.8m |
Other Non-Current Assets | 5.9m |
Free Cash Flow Analysis
Mirum Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Mirum Pharmaceuticals Inc
Revenue
|
379.3m
USD
|
Cost of Revenue
|
-86.8m
USD
|
Gross Profit
|
292.4m
USD
|
Operating Expenses
|
-368.7m
USD
|
Operating Income
|
-76.3m
USD
|
Other Expenses
|
-1m
USD
|
Net Income
|
-77.3m
USD
|
MIRM Profitability Score
Profitability Due Diligence
Mirum Pharmaceuticals Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Score
Mirum Pharmaceuticals Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
MIRM Solvency Score
Solvency Due Diligence
Mirum Pharmaceuticals Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Score
Mirum Pharmaceuticals Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MIRM Price Targets Summary
Mirum Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
MIRM
is 71.74 USD
with a low forecast of 55.55 USD and a high forecast of 82.95 USD.
Dividends
Current shareholder yield for MIRM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MIRM
stock under the Base Case scenario is
44.92
USD.
Compared to the current market price of 50.73 USD,
Mirum Pharmaceuticals Inc
is
Overvalued by 11%.